The good news is that within 3 or 4 months we shal
Post# of 11802
(Total Views: 381)
Posted On: 10/25/2019 8:46:33 PM
The good news is that within 3 or 4 months we shall know if the the appeal is successful or not.
Really, I believe we'll know sometime before Christmas. But then again I don't frequent message boards masquerading as an expert. I AM an expert in my field and I follow the words of other experts.
Isn't Christmas within 3 or 4 months? Unless you are looking at Christmas 2020
Of course, this appeal only speaks to the summary judgment against the Company. Assuming a longshot reversal, the case would then begin the discovery phase, a litany of pleadings and answers will be filed and eventually a trial.
Really, the appeal became less of a long shot when the judges didn't unanimously toss out the appeal. A lot less.
All that means if true is that they will publish an opinion.
As far as the case is concerned, discovery has been completed, depositions taken, expert reports written and the the depositions of experts taken. There are a few additional depositions to take, like for example the J&J Chairman who has a very difficult task explaining his words uttered in public -- 21 times. When this case gets back to Las Vegas, if it is not settled first, DECN will move for a quick Markman Hearing (you know what that is being an expert and all) and then a trial. If J&J is not in the mood to settle and wants to roll the dice. The trial should be in June-August 2020, somewhere in that period. But this case will not go to trial. Too much at stake for J&J to take the risk as they did in the talcum powder cases after killing some people with cancer over Tylenol 5-6 years ago.
Your credibility is not very good! In fact, your track record on predictions is terrible. I remember you stating this case would be heard and decided in the spring. What happened to that licensing deal you previously rambled about?
The Company is in terrible financial straits and any funding the Company gets will continue to massively dilute shareholders.
And you know this how? Because you've run a public company, because you've spoken with Messrs. Berman or Jagunich? In addition to being a worlds expert in diabetic test strips, the guy everyone in the industry calls first, you also are a financing expert for boutique companies like DECN? You do know that DECN can borrow by my guess $5 million against a patent infringement settlement. A loan against a litigation with a potential big outcome, going in the right direction, will create zero dilution. Lots of reputable companies lending money these days. Did they teach that in penny stock trading school?
Why doesn't the Company get the $5,000,000 loan without the dilution? The financial statements speak for themselves. You even whine and complain the Company does not have any funds.
A victory in the appeal will certainly not be as earth-shattering as when the previous litigation found the patent of Johnson and Johnson invalid.
That wasn't the big victory last go-around. The Precidential Ruling over exhaustion flipped J&J's case against DECN and drove the stock over $1.00. The death of a patent over a year later, which went all the way to the Supreme Court, was anti-climatic. It did allow the flips and servile traders to create a short rise to $.45. Then the talk of cash dividend began and the stock retraced. Come on now, you are better than that.
Yeah! Yeah! Yeah! why don't you tell us how many shares were outstanding when the stock ran to $1.00. Give it a rest, this Company now has at least a couple hundred million shares out and who really knows sure how shares could be out when everything is converted or exercised.
It could put the Company in position to get financing or a settlement. This continues to be a very high risk low return play even for investors that have an average cost over .03 pennies.
Oh really? I see it otherwise because I have done a lot of DD on DECN, I understand patent law, and I also know how and when J&J over-reaches. This case is worth a mint.
It is you who overreach. Still not sure why you bash shareholders that have questions or opinions that vary from your opinion of the day.
Really, I believe we'll know sometime before Christmas. But then again I don't frequent message boards masquerading as an expert. I AM an expert in my field and I follow the words of other experts.
Isn't Christmas within 3 or 4 months? Unless you are looking at Christmas 2020
Of course, this appeal only speaks to the summary judgment against the Company. Assuming a longshot reversal, the case would then begin the discovery phase, a litany of pleadings and answers will be filed and eventually a trial.
Really, the appeal became less of a long shot when the judges didn't unanimously toss out the appeal. A lot less.
All that means if true is that they will publish an opinion.
As far as the case is concerned, discovery has been completed, depositions taken, expert reports written and the the depositions of experts taken. There are a few additional depositions to take, like for example the J&J Chairman who has a very difficult task explaining his words uttered in public -- 21 times. When this case gets back to Las Vegas, if it is not settled first, DECN will move for a quick Markman Hearing (you know what that is being an expert and all) and then a trial. If J&J is not in the mood to settle and wants to roll the dice. The trial should be in June-August 2020, somewhere in that period. But this case will not go to trial. Too much at stake for J&J to take the risk as they did in the talcum powder cases after killing some people with cancer over Tylenol 5-6 years ago.
Your credibility is not very good! In fact, your track record on predictions is terrible. I remember you stating this case would be heard and decided in the spring. What happened to that licensing deal you previously rambled about?
The Company is in terrible financial straits and any funding the Company gets will continue to massively dilute shareholders.
And you know this how? Because you've run a public company, because you've spoken with Messrs. Berman or Jagunich? In addition to being a worlds expert in diabetic test strips, the guy everyone in the industry calls first, you also are a financing expert for boutique companies like DECN? You do know that DECN can borrow by my guess $5 million against a patent infringement settlement. A loan against a litigation with a potential big outcome, going in the right direction, will create zero dilution. Lots of reputable companies lending money these days. Did they teach that in penny stock trading school?
Why doesn't the Company get the $5,000,000 loan without the dilution? The financial statements speak for themselves. You even whine and complain the Company does not have any funds.
A victory in the appeal will certainly not be as earth-shattering as when the previous litigation found the patent of Johnson and Johnson invalid.
That wasn't the big victory last go-around. The Precidential Ruling over exhaustion flipped J&J's case against DECN and drove the stock over $1.00. The death of a patent over a year later, which went all the way to the Supreme Court, was anti-climatic. It did allow the flips and servile traders to create a short rise to $.45. Then the talk of cash dividend began and the stock retraced. Come on now, you are better than that.
Yeah! Yeah! Yeah! why don't you tell us how many shares were outstanding when the stock ran to $1.00. Give it a rest, this Company now has at least a couple hundred million shares out and who really knows sure how shares could be out when everything is converted or exercised.
It could put the Company in position to get financing or a settlement. This continues to be a very high risk low return play even for investors that have an average cost over .03 pennies.
Oh really? I see it otherwise because I have done a lot of DD on DECN, I understand patent law, and I also know how and when J&J over-reaches. This case is worth a mint.
It is you who overreach. Still not sure why you bash shareholders that have questions or opinions that vary from your opinion of the day.
(1)
(0)Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼